Dual effects of NV-CoV-2 biomimetic polymer: An antiviral regimen against COVID-19

Remdesivir (RDV) is the only antiviral drug approved for COVID-19 therapy by the FDA. Another drug LAGEVRIO™ (molnupiravir) though has not been approved yet by FDA but has been authorized on December 23, 2021, for emergency use to treat adults with mild-to moderate COVID-19 symptoms and for whom alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Ashok, Diwan, Anil, Chiniga, Vijetha, Arora, Vinod, Holkar, Preetam, Thakur, Yogesh, Tatake, Jay, Barton, Randall, Holkar, Neelam, Pandey, Rajesh, Pond, Bethany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803160/
https://www.ncbi.nlm.nih.gov/pubmed/36584166
http://dx.doi.org/10.1371/journal.pone.0278963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803160/
https://www.ncbi.nlm.nih.gov/pubmed/36584166
http://dx.doi.org/10.1371/journal.pone.0278963

Ejemplares similares